Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring antibiotic and immune activity in the knee after removal of an infected prosthesis and placement of an antibiotic spacer

Official title: Analysis of Immunological and Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Knee Infection During Hospitalization: a Microdialysis Study

Run by University Hospital, Bonn · NCT07299565 · Data updated 2026-11-12

This project will use microdialysis to see if antibiotic levels and immune signals in the knee after spacer placement predict infection-free recovery for people having a two-stage revision for periprosthetic knee infection.

More Periprosthetic Joint Infection trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital, Bonn
Academic / other
Locations1 site (Bonn, North Rhine-Westphalia)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedNovember 1, 2026
Study endsNovember 1, 2027
Registry record updatedDecember 23, 2025
Trial IDNCT07299565 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age >18) who are scheduled for two-stage revision for periprosthetic knee infection, cleared for surgery, and willing to provide informed consent (and without allergy to gentamicin or vancomycin) are ideal candidates.

Probably not a fit

People who are not undergoing a two-stage knee revision, or who have known allergies to the spacer antibiotics (gentamicin or vancomycin), are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study places microdialysis probes in the knee joint after removal of an infected prosthesis and insertion of an antibiotic-impregnated cement spacer to continuously sample local antibiotic concentrations and immunologic markers during the initial hospitalization (typically about 14 days). Blood samples will be collected in parallel to compare systemic and intraarticular antibiotic levels. Clinical outcomes, including reinfection rates, infection-free survival, and functional recovery, will be tracked over a 12-month follow-up. The spacer materials contain gentamicin and vancomycin, and patients with known allergies to these antibiotics are excluded. Data will be analyzed to identify pharmacological and immunological profiles associated with better or worse outcomes after two-stage revision.

Why it matters

Potential benefit: If successful, the results could help tailor local and systemic antibiotic strategies and spacer use to reduce reinfection and improve recovery after two-stage knee revision.

How similar studies have gone: A prior pilot by the same group used microdialysis for 72 hours, providing preliminary feasibility data, but prolonged in vivo monitoring during spacer implantation remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical indication for two-stage revision of knee PJI
* approval for surgery by the orthopedic and anesthesiologic department
* being over 18 years of age
* written, informed consent after detailed patient information about the study protocol and possible study dependent risks

Exclusion Criteria:

* known allergies to antibiotics gentamicin and vancomycin used within the spacer

Where it's running

  • University Hospital Bonn
    Bonn, North Rhine-Westphalia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.